Contact this trialFirst, we need to learn more about you.
Bcl-2 Inhibitor
BGB-11417 +/− Zanubrutinib for B-Cell Lymphoma
Recruiting1 awardPhase 1
Omaha, Nebraska
This trial is testing a new drug called BGB-11417 alone and with two other drugs to see if they are safe and how much can be given without serious side effects. It likely targets patients with certain cancers or blood disorders.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.